Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Current Treatment Options in Oncology|August 10, 2023
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic LeukemiaSaeid Taghiloo, Hossein Asgarian-Omran
Critical Reviews in Oncology/Hematology|December 3, 2020
Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathwaysSaeid Taghiloo, Hossein Asgarian-Omran
European Journal of Haematology|May 3, 2024
Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update reviewSaeid Taghiloo, Hossein Asgarian-Omran
Iranian Journal of Allergy, Asthma, and Immunology|May 1, 2022
The Effects of PI3K/Akt/mTOR Signaling Pathway Inhibitors on the Expression of Immune Checkpoint Ligands in Acute Myeloid Leukemia Cell LineSaeid Taghiloo, Saeid Norozi, Hossein Asgarian-Omran
Iranian Journal of Pharmaceutical Research : IJPR|July 25, 2022
Expression Modulation of Immune Checkpoint Molecules by Ibrutinib and Everolimus Through STAT3 in MCF-7 Breast Cancer CellsMohsen Soltanshahi, Saeid Taghiloo, Hossein Asgarian-Omran
Iranian Journal of Pharmaceutical Research : IJPR|March 4, 2024
Glucose Metabolism in Acute Myeloid Leukemia Cell Line Is Regulated via Combinational PI3K/AKT/mTOR Pathway InhibitorsAbbas Ranjbar, Mohsen Soltanshahi, Saeid Taghiloo, et al.
International Immunopharmacology|November 13, 2023
Combination therapy of acute myeloid leukemia by dual PI3K/mTOR inhibitor BEZ235 and TLR-7/8 agonist R848 in murine modelSaeid Taghiloo, Abolghasem Ajami, Reza Alizadeh-Navaei, et al.
International Immunopharmacology|October 7, 2023
Single domain antibodies specific for HER2 dimerization domain effectively disrupts HER2 dimerizationAhmad Najafi, Reza Valadan, Hossein Asgarian-Omran, et al.
Iranian Journal of Immunology : IJI|March 16, 2022
Treatment by PI3K/mTOR Inhibitor BEZ235 Combined with TLR-7/8 Agonist Interfere with Immune Evasion Mechanisms of WEHI-3 Mouse Leukemia CellsSaeid Taghiloo, Abolghasem Ajami, Reza Alizadeh-Navaei, et al.
Iranian Journal of Allergy, Asthma, and Immunology|January 14, 2023
Detection of Novel Autoantibodies to Nucleolin's RNA-binding Domains as a Serum Tumor Biomarker Through ELISAFatemeh Ezzatifar, Alireza Rafiei, Reza Valadan, et al.
Pageof 11